Trial Profile
A Phase One Open-Label Single-Radiolabeled Dose Study To Investigate The Absorption, Metabolism And Excretion Of [14C] PD 0200390 In Six Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Aug 2008
Price :
$35
*
At a glance
- Drugs Atagabalin (Primary)
- Indications Insomnia
- Focus Pharmacokinetics
- Sponsors Pfizer
- 15 Aug 2008 New trial record.